Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024
Compare Balance Sheet Results of Aptus Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.00
21.04
-16.04
-76.24%
Share Warrants & Outstandings
Total Reserve
1.97
160.76
-158.79
-98.77%
Shareholder's Funds
6.97
181.80
-174.83
-96.17%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.62
0.00
2.62
0.00%
Secured Loans
1.51
0.00
1.51
0.00%
Unsecured Loans
1.11
0.00
1.11
0.00%
Deferred Tax Assets / Liabilities
-0.07
4.49
-4.56
-101.56%
Other Long Term Liabilities
0.25
0.00
0.25
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.80
4.49
-1.69
-37.64%
Current Liabilities
Trade Payables
1.31
18.68
-17.37
-92.99%
Other Current Liabilities
3.04
22.42
-19.38
-86.44%
Short Term Borrowings
7.74
0.03
7.71
25,700.00%
Short Term Provisions
0.00
5.56
-5.56
-100.00%
Total Current Liabilities
12.08
46.69
-34.61
-74.13%
Total Liabilities
21.85
232.98
-211.13
-90.62%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.86
51.22
-49.36
-96.37%
Less: Accumulated Depreciation
0.87
30.57
-29.70
-97.15%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.99
20.65
-19.66
-95.21%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
18.76
-18.76
-100.00%
Long Term Loans & Advances
0.00
0.72
-0.72
-100.00%
Other Non Current Assets
1.12
1.40
-0.28
-20.00%
Total Non-Current Assets
2.11
41.53
-39.42
-94.92%
Current Assets Loans & Advances
Current Investments
0.00
110.50
-110.50
-100.00%
Inventories
7.06
17.64
-10.58
-59.98%
Sundry Debtors
5.64
46.83
-41.19
-87.96%
Cash and Bank
5.21
1.68
3.53
210.12%
Other Current Assets
0.00
3.90
-3.90
-100.00%
Short Term Loans and Advances
1.82
10.91
-9.09
-83.32%
Total Current Assets
19.74
191.45
-171.71
-89.69%
Net Current Assets (Including Current Investments)
7.65
144.77
-137.12
-94.72%
Total Current Assets Excluding Current Investments
19.74
80.96
-61.22
-75.62%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
21.85
232.98
-211.13
-90.62%
Contingent Liabilities
0.00
6.65
-6.65
-100.00%
Total Debt
10.36
0.03
10.33
34,433.33%
Book Value per share (adjusted)
13.93
86.41
-72.48
-83.88%
Annual - Borrowings
Borrowings 10.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 95.10% vs 140.27% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.25 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 47.06% vs 54.55% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 57.14% vs 21.15% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 19.74 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 137.26% vs 47.26% in Mar 2024






